Welcome to our dedicated page for Amer Shared Hosp news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on Amer Shared Hosp stock.
American Shared Hospital Services provides stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through equipment leasing and direct patient care services. Company news commonly covers quarterly results, procedure and treatment volumes, Gamma Knife sites, LINAC centers, proton beam radiation therapy leases, and the expansion of stand-alone radiation therapy treatment centers in the United States and Latin America.
Updates also address health system partnerships, revenue mix between leasing and direct patient services, equipment upgrades such as Gamma Knife platform improvements, and operating activity at centers including Rhode Island and Puebla, Mexico.
American Shared Hospital Services (NYSE American: AMS) reported first quarter 2026 revenue of $7.1 million, up 15.9% year-over-year, driven by 30.2% growth in direct patient services to $4.1 million.
Gross margin rose to $1.3 million (18.2%), adjusted EBITDA increased 18.4% to $1.1 million, and operating loss narrowed to $0.9 million, while net loss remained $0.6 million. Gamma Knife procedures grew 10.1% and PBRT treatments 20.7%. Cash increased to $5.2 million, and current long-term debt was $16.8 million.
American Shared Hospital Services (NYSE American: AMS) will host a conference call to discuss its first quarter 2026 financial results on May 14, 2026 at 12:00 PM ET. The related earnings release will be issued before the market opens that day.
Investors can join via teleconference or webcast, with replays available through May 21, 2026.
American Shared Hospital Services (NYSE: AMS) reported full year 2025 revenue of $28.1 million and a net loss attributable to shareholders of $1.6 million (loss of $0.23 per diluted share). The company announced a seven-year PBRT lease extension with Orlando Health through 2033.
Key metrics: LINAC revenue $11.5M (+35.4% YoY), Gamma Knife revenue $9.2M (-5.5% YoY), PBRT revenue $7.4M (-26.0% YoY). Cash was $3.7M; current portion of long-term debt approx. $17.3M; shareholders' equity $24.0M ($3.66/share).
American Shared Hospital Services (NYSE American: AMS) will host a conference call to review fourth quarter and full year 2025 financial results on March 31, 2026 at 12:00 PM ET. The company will issue its results press release before market open on March 31.
Teleconference and webcast access, plus replay details through April 7, 2026, are available via the company website and provided dial‑in numbers.
American Shared Hospital Services (NYSE: AMS) reported Q3 2025 results on November 13, 2025: Q3 revenue $7.2M (+2.5% period over period) and adjusted EBITDA $1.94M (+42.3% YoY). Q3 direct patient services revenue rose 9.4% to $4.0M and represented 56% of sales. Nine-month revenue was $20.4M (+5.6% YoY) with direct patient care revenue up 36.5% to $10.7M. The company signed a 10-year extension and Esprit upgrade with an existing health system and cited new centers in Puebla and planned Guadalajara startup in Q2 2026. Cash totaled $5.3M at Sept 30, 2025 after $7.5M CapEx.
American Shared Hospital Services (NYSE American: AMS) will hold a conference call to discuss third quarter 2025 financial results on November 13, 2025 at 1:00 PM ET. The company will issue the Q3 2025 press release before market open on November 13, 2025. Domestic callers should dial 1-844-413-3972; international callers should dial 1-412-317-5776 and join the American Shared Hospital Services call.
A simultaneous webcast will be available at www.ashs.com or via the direct webcast link. A replay will be available by phone at 1-855-669-9658 or 1-412-317-0088 (access code 7027755) through November 20, 2025, and on the company website.
American Shared Hospital Services (NYSE American: AMS) reported Q2 2025 financial results, with total revenue increasing 16% sequentially to $7.07 million, a slight 0.2% increase year-over-year. The company's direct patient services segment grew 11% year-over-year to $3.5 million, while medical equipment leasing revenue declined 8% to $3.57 million.
Q2 2025 resulted in a net loss of $280,000 ($0.04 per share), compared to net income of $3.6 million in Q2 2024, which included a one-time gain. Adjusted EBITDA was $1.7 million, down from $2.01 million in Q2 2024. The company maintains a strong balance sheet with $11.33 million in cash and shareholders' equity of $24.48 million ($3.78 per share).
Strategic expansion continues with a new Esprit installation in Guadalajara, Mexico, and Certificate of Need approvals for radiation therapy centers in Rhode Island.
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, has scheduled its Q2 2025 earnings conference call for August 13, 2025, at 1:00 PM ET. The company will release its financial results before market opens on the same day.
Investors can join the call by dialing 1-844-413-3972 (domestic) or 1-412-317-5776 (international). A webcast will be available through the company's website. A replay will be accessible until August 20, 2025, using access code 3350902.
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, has scheduled its first quarter 2025 financial results conference call for May 15th at 12:00 PM ET. The financial results press release will be issued before market opening on the same day.
Domestic participants can dial 1-844-413-3972, while international callers should use 1-412-317-5776. The call will be accessible via webcast through the company's website or directly via the provided link. A replay will be available until May 22, 2025, through multiple channels including the company's website.